BROLUCIZUMAB-DBLL vs BROMFENAC: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BROLUCIZUMAB-DBLL vs BROMFENAC: Safety Overview
| Metric | BROLUCIZUMAB-DBLL | BROMFENAC |
|---|---|---|
| Total FAERS Reports | 2,802 | 1,185 |
| Deaths Reported | 198 | 1 |
| Death Rate | 7.1% | 0.1% |
| Hospitalizations | 170 | 35 |
| Average Patient Age | 76.6 yrs | 70.5 yrs |
| % Female Patients | 57.3% | 66.2% |
| FDA Approval Date | N/A | Apr 5, 2013 |
| Manufacturer | N/A | Alembic Pharmaceuticals Limited |
| Route | N/A | OPHTHALMIC |
| Marketing Status | Prescription | Discontinued |